Is Evogene Ltd (EVGN) the Top Pick in the Biotechnology Industry?

Thursday, September 24, 2020 2:46 PM | InvestorsObserver Analysts

Evogene Ltd (EVGN) is near the top in its industry group according to InvestorsObserver. EVGN gets an overall rating of 65. That means it scores higher than 65 percent of stocks. Evogene Ltd gets a 83 rank in the Biotechnology industry. Biotechnology is number 35 out of 148 industries.

Overall Score - 65
EVGN has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on EVGN!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Evogene Ltd Stock Today?

Evogene Ltd (EVGN) stock is trading at $3.22 as of 2:40 PM on Thursday, Sep 24, an increase of $0.30, or 10.48% from the previous closing price of $2.91. The stock has traded between $2.76 and $3.31 so far today. Volume today is 936,084 compared to average volume of 928,079.

Click Here to get the full Stock Score Report on Evogene Ltd (EVGN) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Sector Update: Biotech Stocks Help Drag Health Care Sector Lower

Sector Update: Health Care

How Will the Market React to Gamida Cell Ltd (GMDA) Stock Getting a Bullish Rating

Is OrganiGram Holdings Inc (OGI) Stock About to Get Hot Monday?

Related Companies